0001193125-20-268501.txt : 20201113 0001193125-20-268501.hdr.sgml : 20201113 20201013163001 ACCESSION NUMBER: 0001193125-20-268501 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 CORRESP 1 filename1.htm CORRESP

Royalty Pharma plc

110 East 59th Street Suite 3300

New York, New York 10022

VIA EDGAR TRANSMISSION

October 13, 2020

U.S. Securities and Exchange Commission

Office of Life Sciences

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Campbell

RE: Royalty Pharma plc Registration Statement on Form S-1, as amended (File No. 333-249454) Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on October 15, 2020, or as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

Please contact Richard D. Truesdell, Jr. of Davis Polk & Wardwell LLP at (212) 450-4674 as soon as the Registration Statement has been declared effective or with any questions or comments with respect to this letter.

[Signature Page Follows]

Sincerely,

 

ROYALTY PHARMA PLC

By:

  

/s/ Pablo Legorreta

  Name:  Pablo Legorreta
  Title:    Chief Executive Officer

CC: Richard D. Truesdell, Jr., Davis Polk & Wardwell LLP